SII Cites UK Nod, Seeks Covishield Booster Tag
The Times of India Mumbai|December 02, 2021
Serum Institute of India has sought approval from India’s drug regulator for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.

Continue reading your story on the app

Continue reading your story in the newspaper

MORE STORIES FROM THE TIMES OF INDIA MUMBAIView All

₹ 4cr gold stolen from SoBo jeweller squirrelled away in Raj field, 10 held

Mumbai: Two weeks after 17.5kg of gold worth Rs 8.19 crore was stolen from a jeweller’s office in Bhuleshwar, a 21-year-old worker has been arrested besides nine of his accomplices for the theft.

2 mins read
The Times of India Mumbai
January 29, 2022

Ukraine tensions: India tries to appear neutral

Ties With Both US And Russia Critical For India

1 min read
The Times of India Mumbai
January 29, 2022

Trailer of Rajkummar and Bhumi's Badhaai Do gets lots of love

Badhaai Do, a sequel to the multiple National Award-winning film Badhaai Ho, stars Rajkummar Rao and Bhumi Pednekar

2 mins read
The Times of India Mumbai
January 29, 2022

Spirit of ‘nation first': Modi's mantra for youth at NCC rally

Exhorts Youth To Spread ‘Vocal For Local’ Drive

1 min read
The Times of India Mumbai
January 29, 2022

Sahara cos raised ₹ 50k cr, did not pay back investors: SFIO

Asks SC To Lift HC Stay On Probe

2 mins read
The Times of India Mumbai
January 29, 2022

Pvt med edu fees rise 2%-10%; parents seek check on deposits

Mumbai: Fees at several private medical colleges have gone up by 2% to 10%. Most colleges had sought higher fee hikes this year, citing a deficit in hospital revenue in the pandemic.

2 mins read
The Times of India Mumbai
January 29, 2022

PM to address his 1st UP virtual rally on Jan 31

Lucknow: Prime Minister Narendra Modi would be addressing his first virtual political rally of the Uttar Pradesh campaign on January 31, primarily for the districts voting in the first phase.

1 min read
The Times of India Mumbai
January 29, 2022

Namaste, Shalom To Friendship

Foreign ministers of India, Israel write to mark the 30th anniversary of establishing full diplomatic ties

4 mins read
The Times of India Mumbai
January 29, 2022

Legislators' House conduct draws SC's disapproval

New Delhi: With scenes of unruly behavior in the House by members of legislative bodies, including Parliament, becoming frequent in recent times, the Supreme Court on Friday expressed deep concern over the deterioration as most of the time is spent “in jeering and personal attacks against each other instead of erudite constructive and educative debates consistent with the highest tradition of the august body”.

1 min read
The Times of India Mumbai
January 29, 2022

Indian hockey seeks consistency in new season

Bengaluru: In the world of sports where bio-bubbles, constant Covid-19 testing and tournament behind closed doors have become the norm, the functioning of teams, focus and planning have seen a lateral shift.

2 mins read
The Times of India Mumbai
January 29, 2022
RELATED STORIES

Covishield, Covaxin Receive Conditional Market Approval

The Drugs Controller General of India (DCGI) has given its nod to the market authorisation of two Covid vaccines — Bharat Biotech's Covaxin and Serum Institute of India's (SII's) Covishield --for use in the adult population, subject to certain conditions, said a Union health ministry statement on Thursday.

1 min read
Business Standard
January 28, 2022

Young women flag vax 'effects on menstruation

While docs in city dismiss links with Covid vaccines, research finally begins abroad

3 mins read
The New Indian Express
December 14, 2021

Govt: 2k serious cases of AEFI, 0.004% of 123cr shots given

Of 50k Reported Adverse Events After Vax, Over 47k Were Minor

2 mins read
The Times of India Delhi
December 08, 2021

कोविशील्ड की बूस्टर खुराक को मिले मंजूरी : सीरम

सीरम इंस्टीट्यूट आफ इंडिया ने कहा है, देश में टीके का पर्याप्त भंडार है और संक्रमण के नए बहुरूप को देखते हुए बूस्टर खुराक की जरूरत है। सीरम इंस्टीट्यूट आफ इंडिया में सरकार और नियामक मामलों के निदेशक प्रकाश कुमार सिंह ने कह, ब्रिटेन की औषधि एवं स्वास्थ्य देखभाल उत्पाद नियामक एजंसी ने पहले ही एस्ट्राजेनेका की बूस्टर खुराक को मंजूरी दे दी है।

1 min read
Jansatta Delhi
December 02, 2021

टीके की 50 लाख खुराक चार देशों को भेजने की अनुमति दी

केंद्र सरकार ने सीरम इंस्टीट्यूट आफ इंडिया (एसआइआइ) को संयुक्त राष्ट्र समर्थित कोवैक्स वैश्विक टीकाकरण कार्यक्रम के तहत कोरोनारोधी टीके कोविशील्ड की 50 लाख खुराक नेपाल, ताजिकिस्तान और मोजाम्बिक को निर्यात करने की अनुमति दी है।

1 min read
Jansatta Delhi
November 22, 2021

कोविशील्ड और कोवैक्सीन को 96 देशों ने दी मान्यता

बाकी देशों के साथ भी बातचीत जारी : मनसुख मंडाविया

1 min read
Aaj Samaaj
November 11, 2021

टीके की रफ्तार कम हुई तो दो फ्लाइट से आ गई वैक्सीन की सात लाख खुराक

दो फ्लाइट में पहुंचे वैक्सीन के करीब साठ पैकेट

1 min read
Hari Bhoomi
November 03, 2021

The vaccination journey: It's a bridge not too far

100 crore vaccinations in 270 days are simply breathtaking.

3 mins read
The Sunday Guardian
October 24, 2021

कोविशील्ड पर भारत व ब्रिटेन में सहमति, निर्बाध होगी यात्रा

नागरिकों को अब नहीं रहना होगा क्वारंटाइन

1 min read
Aaj Samaaj
October 14, 2021

CoWin to add date of birth for fully jabbed travelling abroad

India logs 29,616 new Covid cases, 290 fatalities

2 mins read
Millennium Post Delhi
September 26, 2021